• FirefoxInstall the new Firefox »
  •  Dow Down0.41% Nasdaq Down0.48%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    12.64 Up 0.23(1.85%) 10:07AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.7
    Mean Recommendation (last week):1.7
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:24.58
    Median Target:25.00
    High Target:32.00
    Low Target:19.00
    No. of Brokers:12

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 8, 2014FBR CapitalDowngradeMkt PerformUnderperform
    Aug 14, 2014FBR CapitalInitiated Mkt Perform
    Mar 21, 2014MizuhoInitiated Buy
    Dec 13, 2012Maxim GroupInitiated Buy
    Nov 13, 2012Burrill Institutional ResearchInitiated Mkt Outperform
    May 10, 2012Ladenburg ThalmannUpgradeNeutralBuy
    Apr 3, 2012Ladenburg ThalmannDowngradeBuyNeutral
    May 17, 2011OppenheimerInitiated Outperform
    May 6, 2011MLV CapitalInitiated Buy
    Mar 16, 2011JMP SecuritiesInitiated Mkt Outperform

    More Upgrades & Downgrades for KERX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy3344
    Buy8887
    Hold0000
    Underperform0000
    Sell0011

    Data provided by Thomson/First Call


    Currency in USD.